Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
25 participants
INTERVENTIONAL
2025-09-19
2025-10-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Rehabilitation of Partially Injured Hamstring Muscles
NCT06165783
Hamstring Strain in High School Athletes
NCT03248011
Effects of Warm up in Athletes With Previous Hamstring Injury
NCT03444285
System Dynamics Model for Acute Non-contact Lower Extremity Injuries Prediction
NCT05425303
Muscle Injury RTP Design in Football; Effects of Backward Design vs Forward Design.
NCT07012408
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SEQUENTIAL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Therapeutic Exercise + Amino Acid Supplementation
Participants in this arm will undergo a structured 6-week therapeutic exercise rehabilitation program combined with daily oral branched-chain amino acid (BCAA) supplementation (10 g per day, divided into two doses: pre-training and post-training). The exercise program includes progressive isometric, eccentric, plyometric, and sprint-specific training to optimize hamstring recovery.
Branched-Chain Amino Acid Supplement
Oral BCAA blend (leucine, isoleucine, valine), 10 g/day divided into two doses, pre- and post-training, for 6 weeks.
Therapeutic Exercise Program
6-week structured program including isometric, eccentric, plyometric, and sprint-specific exercises.
Therapeutic Exercise Only
Arm Description:
Participants in this arm will undergo the same structured 6-week therapeutic exercise rehabilitation program without any amino acid supplementation. The exercise program includes progressive isometric, eccentric, plyometric, and sprint-specific training for hamstring recovery.
Branched-Chain Amino Acid Supplement
Oral BCAA blend (leucine, isoleucine, valine), 10 g/day divided into two doses, pre- and post-training, for 6 weeks.
Therapeutic Exercise Program
6-week structured program including isometric, eccentric, plyometric, and sprint-specific exercises.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Branched-Chain Amino Acid Supplement
Oral BCAA blend (leucine, isoleucine, valine), 10 g/day divided into two doses, pre- and post-training, for 6 weeks.
Therapeutic Exercise Program
6-week structured program including isometric, eccentric, plyometric, and sprint-specific exercises.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Active players from eight clubs in the Iraqi Football League.
* MRI-confirmed partial hamstring muscle injury.
* No participation in other ongoing rehabilitation programs.
Exclusion Criteria
* Any other musculoskeletal injuries affecting lower limbs.
* Contraindications for MRI scanning (e.g., metal implants, pacemakers).
* Any existing neurological or metabolic conditions affecting muscle recovery.
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad de Zaragoza
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kamal Hadib Abdulridha
PhD Student
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Unizar
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.